PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis (Q57802755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

title

PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

4

Nader G Abraham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

author name string

Maayan Waldman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Vadim Nudelman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Asher Shainberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Ran Kornwoski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Dan Aravot

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Michael Arad

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Edith Hochhauser

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

language of work or name

English

0 references

publication date

23 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

30 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

volume

373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

112-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

30 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Diabetic cardiomyopathy: pathophysiology and clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Oxidative stress and myocardial injury in the diabetic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Attenuation of diabetes-induced cardiac inflammation and pathological remodeling by low-dose radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Pathophysiology of obesity hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Profibrotic effects of angiotensin II in the heart: a matter of mediators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Poly(ADP-ribose): novel functions for an old molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Ca2+-induced PARP-1 activation and ANF expression are coupled events in cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Poly(ADP-Ribose) Polymerase Promotes Cardiac Remodeling, Contractile Failure, and Translocation of Apoptosis-Inducing Factor in a Murine Experimental Model of Aortic Banding and Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Caloric restriction ameliorates cardiomyopathy in animal model of diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Correction to: Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Ras inhibition attenuates myocardial ischemia-reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

An ultra-low dose of tetrahydrocannabinol provides cardioprotection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Interplay of chromatin modifications and non-coding RNAs in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

PARP1 orchestrates epigenetic events setting up chromatin domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Poly(ADP-ribose) polymerases as modulators of mitochondrial activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

A nexus for cellular homeostasis: the interplay between metabolic and signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Metabolic control through the PGC-1 family of transcription coactivators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

EET intervention on Wnt1, NOV, and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

Protective role of PGC-1α in diabetic nephropathy is associated with the inhibition of ROS through mitochondrial dynamic remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.10.003

10.1016/J.YEXCR.2018.10.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30359575%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference